Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Freitag Gregory Gene, Director. Director active across 2 companies, notably Axogen, Inc.. Cumulatively, 16 reports have been logged. Breakdown: 2 buys · 7 sells. Total volume traded: €1.1m. Activity tracked since 26 May 2021. The latest transaction was disclosed on 28 February 2025 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Freitag Gregory Gene
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22,954 shares@ US$3.673.8% of flowCommon StockSEC:0000805928-21-000099:0
16 of 16 declarations
About Freitag Gregory Gene
Freitag Gregory Gene is Administrateur and is involved with Axogen, Inc. and PDS Biotechnology Corp, where he is a Director. He has 16 filings in total, and across the sampled filings from 2021-05-28 to 2025-03-03, buys amount to EUR 65277 and sells to EUR 986368, with Cession as the modal transaction nature.